Insider trades
Atul Pande, Director of Immunovant IMVT, has filed 0 purchases and 7 sales on the open market. Over the past 12 months that comes to a net sale of $300K. The latest trade was on 06/26.
Atul Pande
Director
- Company
- Immunovant IMVT
- First filing
- 23/04/14
- Trades
- 28 trades
- Buys / sales
- 0 / 7
- 12-month net buying
- −$300K
- Last trade
- 06/26
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ImmunovantIMVT | Open-market sale10b5-1 plan | 06/26 | 06/26 | 1,500 sh | $38.01 | $57,015 | −1.3% |
ImmunovantIMVT | Open-market sale10b5-1 plan | 06/15 | 06/16 | 1,500 sh | $34.02 | $51,030 | −1.3% |
ImmunovantIMVT | Open-market sale10b5-1 plan | 05/20 | 05/20 | 6,000 sh | $32.00 | $192,000 | −4.9% |
ImmunovantIMVT | Open-market sale10b5-1 plan | 24/12/02 | 24/12/04 | 7,750 sh | $28.54 | $221,185 | −8.2% |
| Open-market sale10b5-1 plan | 23/12/01 | 23/12/05 | 12,350 sh3 trades | $39.73avg. | $490,667.5 | −12.9% |